Dual-Target CAR-NK Cells for Advanced Breast Cancer HER2+ TNBC

NCT07510802 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer (Advanced/Metastatic)
HER2-positive Breast Cancer
Triple-negative Breast Cancer

Interventions

BIOLOGICAL: Dual-target CAR-NK cells
DRUG: Lymphodepleting
OTHER: Supportive care

Sponsor

Beijing Biotech